Pay in 4 interest-free payments of $5.44 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Table 12: Results at Week 24 (LOCF*) in an Active-Controlled Trial of Dapagliflozin Initial Combination Therapy with Metformin HCl Extended-Release in Adults with Type 2 Diabetes Mellitus Dapagliflozin Add-On To Metformin HCl Immediate-Release A total of 546 adult patients with type 2 diabetes mellitus with inadequate glycemic control (HbA1c 7% and 10%) participated in a 24-week, placebo-controlled trial to evaluate dapagliflozin in combination with metformin HCl (NCT00528879)
Blood sugar levels can be affected by stress, illness, surgery, exercise, alcohol use, or skipping meals
At this stage, physicians start discussing alternative approaches
Tejera-Prez, C
US$ 26.26
US$ 29.96
US$ 28.39
US$ 23.81
US$ 26.54
US$ 27.86
